A July 2, 2016 article from Judith Graham looks at the recent wave of state Medicaid programs to increase access to Hepatitis C medications in the light of potential litigation from the Center for Health Law and Policy Innovation, its partners, and other organizations.
“Help with the high cost of hepatitis C drugs,” which ran in both USA Today and Kaiser Health News, looks at recent changes in access in Florida, New York, Delaware, Washington, and most recently, Massachusetts.
Excerpt from article:
“Costello’s (Kevin Costello, director of litigation at Harvard Law School’s Center for Health Law & Policy Innovation) center was a key player in the lawsuits in Washington state and Delaware and plans to bring similar actions elsewhere. ‘A 50 state solution is what we’re looking for,’ he said.”
Read the full article “Help with the high cost of hepatitis C drugs” in USA Today.
Health Law & Policy, Commentary
Medicaid Section 1115 Waivers for Reentry: Updates and Resources – Health Care in Motion
April 17, 2024